Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARAVLO-HF
NCT04206865Phase 4Withdrawn
- Sponsor
- Cleveland Clinic
- Start
- Nov 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in heart failure (HF), sponsored by Cleveland Clinic. Planned start Nov 2019; status: withdrawn.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04206865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04206865.